Literature DB >> 2013513

Concentrations of ampicillin and sulbactam in serum and tissues of patients undergoing ENT surgery.

A Wildfeuer1, H Luckhaupt, M Springsklee.   

Abstract

2 g ampicillin and 1 g sulbactam were given by infusion to 24 patients who were to be operated on in the ENT region. About 1 hour later during the operation samples of serum and of various tissues were taken and analysed for ampicillin and sulbactam. The mean serum concentrations of ampicillin and sulbactam were 59.2 mg/l and 31.6 mg/l, respectively. At the same time the concentrations of the two drugs were usually lower in the tissues than in serum. About 1 hour after the infusion the mean tissue concentration of ampicillin was 33.5 mg/kg and of sulbactam 19.5 mg/kg. The results show that ampicillin and sulbactam penetrate within an hour into the different tissues affected by the operation and maintain about the same ratio as in serum (2:1). The concentrations of ampicillin and sulbactam measured in the different compartments are capable of inhibiting the bacteria most frequently involved in ENT infections. These measurements unequivocally support the use of the ampicillin/sulbactam combination in the treatment and perioperative prophylaxis of bacterial infections of the ENT tract.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2013513     DOI: 10.1007/bf01643766

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

1.  [How I do it. Perioperative preventive use of antibiotics in tumor surgery of the head and neck].

Authors:  H Luckhaupt
Journal:  Laryngorhinootologie       Date:  1989-10       Impact factor: 1.057

2.  CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization.

Authors:  A R English; J A Retsema; A E Girard; J E Lynch; W E Barth
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

3.  Sulbactam/ampicillin in the treatment of acute epiglottitis in children.

Authors:  E Wald; J S Reilly; C D Bluestone; D Chiponis
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

4.  Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.

Authors:  J A Retsema; A R English; A Girard; J E Lynch; M Anderson; L Brennan; C Cimochowski; J Faiella; W Norcia; P Sawyer
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

5.  Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections.

Authors:  D S Kernodle; D C Classen; J P Burke; A B Kaiser
Journal:  JAMA       Date:  1990-02-16       Impact factor: 56.272

6.  In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.

Authors:  A F Schmalreck; A Wildfeuer
Journal:  Arzneimittelforschung       Date:  1990-10

7.  Pharmacokinetics of sulbactam and ampicillin intravenously applied in combination to healthy volunteers and patients. Determination of the ratio of the two drugs in serum and in various tissues.

Authors:  A Wildfeuer; U Schwiersch; K Engel; E von Castell; A Schilling; J Potempa; H Lenders
Journal:  Arzneimittelforschung       Date:  1988-11

8.  Pharmacokinetics of sulbactam in humans.

Authors:  G Foulds; J P Stankewich; D C Marshall; M M O'Brien; S L Hayes; D J Weidler; F G McMahon
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

  8 in total
  1 in total

1.  [Ampicillin and sulbactam concentrations in the irradiated mandible after oral squamous cell cancer].

Authors:  H Heibel; M Scheer; T Reuther; M Hahn; R Trittler; H Egle; K Kümmerer; A C Kübler
Journal:  Mund Kiefer Gesichtschir       Date:  2005-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.